[1] Woo HD, Kim K, Kim J. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis[J]. Cancer Cause Control,2015,26(11):1661-1670. [2] 陈胜华. 不同方法治疗大肠癌的临床效果研究[J]. 中国当代医药,2014,21(1):117-118. [3] Wu SH, Liu J, Wang XH, et al. Association of obesity and overweight with overall survival in colorectal cancer patients: a meta-analysis of 29 studies[J]. Cancer Cause Control,2014,25(11):1489-1502. [4] 杨天明. 116例大肠癌患者临床病理特征及生存率分析[J]. 中国医药导刊,2014,16(4):602-603. [5] 袁瑜,黄素娴,洪楚源, 等. Dukes A、B期大肠癌术后总生存率及无瘤生存率分析[J]. 中华全科医学,2011,9(1):5-6, 107. [6] Postlewait LM, Squires MH, Kooby DA, et al. A multi-institutional analysis of 429 patients undergoing major hepatectomy for colorectal cancer liver metastases: the impact of concomitant bile duct resection on survival[J]. J Surg Oncol,2015,112(5):524-528. [7] Fournier E, Jooste V, Woronoff AS, et al. Health-related quality of life is a prognostic factor for survival in older patients after colorectal cancer diagnosis: a population-based study[J]. Dig Liver Dis, 2016,48(1):87-93. [8] Pietrantonio F, Aprile G, Rimassa L, et al. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer[J]. Radiother Oncol, 2015,117(2):315-321. [9] Jawed I, Wilkerson J, Prasad V, et al. Colorectal cancer durvival gains and novel treatment regimens: a systematic review and analysis[J]. JAMA Oncol, 2015,1(6):787-795. [10] Fatemi SR, Pourhoseingholi MA, Asadi F, et al. Recurrence and five year survival in colorectal cancer patients after surgery[J]. Iran J Cancer Prev,2015, 8(4):e3439. [11] 张莉,李冰,王俊伟,等. 大肠癌140例的临床病理及预后分析[J]. 中国中医药科技,2014,21(2):148.
2017, Vol. 24 
